These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20603031)

  • 1. Mechanism of hemostasis defects and management of bleeding in patients with acute coronary syndromes.
    Mannucci PM; Franchini M
    Eur J Intern Med; 2010 Aug; 21(4):254-9. PubMed ID: 20603031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications and management of bleeding events in patients with acute coronary syndromes.
    De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Coronary Syndromes and Percutaneous Coronary Interventions: impact of bleeding and blood transfusion.
    Bassand JP
    Hamostaseologie; 2009 Nov; 29(4):381-7. PubMed ID: 19882079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk.
    Bassand JP
    Int J Cardiol; 2013 Feb; 163(1):5-18. PubMed ID: 22100180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.
    Rao SV; Kaul PR; Liao L; Armstrong PW; Ohman EM; Granger CB; Califf RM; Harrington RA; Eisenstein EL; Mark DB
    Am Heart J; 2008 Feb; 155(2):369-74. PubMed ID: 18215610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality.
    Sobieraj-Teague M; Gallus AS; Eikelboom JW
    Curr Opin Cardiol; 2008 Jul; 23(4):327-34. PubMed ID: 18520716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology.
    Steg PG; Huber K; Andreotti F; Arnesen H; Atar D; Badimon L; Bassand JP; De Caterina R; Eikelboom JA; Gulba D; Hamon M; Helft G; Fox KA; Kristensen SD; Rao SV; Verheugt FW; Widimsky P; Zeymer U; Collet JP
    Eur Heart J; 2011 Aug; 32(15):1854-64. PubMed ID: 21715717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes.
    Rao SV; Eikelboom JA; Granger CB; Harrington RA; Califf RM; Bassand JP
    Eur Heart J; 2007 May; 28(10):1193-204. PubMed ID: 17456480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
    Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
    Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation: hemostasis and thrombin regulation.
    Tanaka KA; Key NS; Levy JH
    Anesth Analg; 2009 May; 108(5):1433-46. PubMed ID: 19372317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study.
    Huynh T; Piazza N; DiBattiste PM; Snapinn SM; Wan Y; Pharand C; Theroux P
    Int J Cardiol; 2005 Apr; 100(1):73-8. PubMed ID: 15820288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in antiplatelet/antithrombotic use in acute coronary syndromes and in-hospital major bleeding complications.
    Motivala AA; Tamhane U; Saab F; Li J; Rogers EK; Froehlich J; Moscucci M; Eagle KA; Gurm HS
    Am J Cardiol; 2007 Nov; 100(9):1359-63. PubMed ID: 17950790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.